Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PTHL

Pheton Holdings Ltd

Dec 13 • 04:00PM ET

4.00

Dollar change -0.15
Percentage change -3.61	%

Healthcare • Medical Devices • China • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.03	Insider Own	78.25%	Shs Outstand	6.83M	Perf Week	-7.62%
Market Cap	57.00M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	3.10M	Perf Month	-5.21%
Income	-0.44M	PEG	-	EPS next Q	-	Inst Own	1.00%	Short Float	0.00%	Perf Quarter	-10.91%
Sales	0.57M	P/S	100.00	EPS this Y	-	Inst Trans	-	Short Ratio	0.00	Perf Half Y	-
Book/sh	0.00	P/B	3571.43	EPS next Y	-	ROA	-31.50%	Short Interest	0.00M	Perf Year	-
Cash/sh	0.00	P/C	1900.00	EPS next 5Y	-	ROE	-188.15%	52W Range	3.32 - 6.45	Perf YTD	5.82%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-490.28%	52W High	-37.98%	Beta	-
Dividend TTM	-	Quick Ratio	0.20	Sales past 5Y	-5.40%	Gross Margin	84.33%	52W Low	20.48%	ATR (14)	0.45
Dividend Ex-Date	-	Current Ratio	0.23	EPS Y/Y TTM	-522.45%	Oper. Margin	-92.02%	RSI (14)	42.50	Volatility	9.55% 9.63%
Employees	-	Debt/Eq	19.00	Sales Y/Y TTM	2.32%	Profit Margin	-77.36%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	3.50	EPS Q/Q	-239.66%	Payout	-	Rel Volume	0.98	Prev Close	4.15
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-21.10%	Earnings	-	Avg Volume	170.10K	Price	4.00
SMA20	-10.02%	SMA50	-12.01%	SMA200	-11.84%	Trades		Volume	166,448	Change	-3.61%

Sep-06-24 04:08PM	Pheton Holdings Ltd Announces Closing of Initial Public Offering (GlobeNewswire) -9.23%
Sep-05-24 09:31AM	Pheton Holdings Ltd Announces Pricing of Initial Public Offering (GlobeNewswire)

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded on November 2, 2022 and is headquartered in Beijing, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PTHL

Pheton Holdings Ltd

Upgrade your FINVIZ experience